Stockreport

Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company fo [Read more]